Patients with human severe combined immunodeficiency (SCID) can be div
ided into those with B lymphocytes (B+ SCID) and those without (B- SCI
D). Although several genetic causes are known for B+ SCID, the etiolog
y of B- SCID has not been defined. Six of 14 B- SCID patients tested w
ere found to carry a mutation of the recombinase activating gene 1 (RA
G-1), RAG-2, or both. This mutation resulted in a functional inability
to form antigen receptors through genetic recombination and links a d
efect in one of the site-specific recombination systems to a human dis
ease.